BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2007
View Archived Issues
Enzyme inhibitors identified at Schering-Plough with potential in inflammatory disorders
Read More
New anticancer agents claimed by several research groups
Read More
GlaxoSmithKline reports second quarter 2007 results
Read More
Prx2: a novel therapeutic target in Parkinson's disease
Read More
Cell Therapeutics to acquire Zevalin from Biogen Idec for U.S. sales and marketing
Read More
DelSite begins toxicology studies of GelVac nasal powder H5N1 vaccine
Read More
Neopharm provides pipeline update
Read More
Positive results for Novo Nordisk's phase III studies of liraglutide
Read More
FDA approvable letter issued for Indevus' drug candidate Valstar
Read More
Phase III trial reveals phenylalanine reductions with sapropterin
Read More
Sinovac prepares to move its H5N1 vaccine into phase II trials
Read More
DNA vaccine shows promise in multiple sclerosis
Read More
Phenoxodiol may reduce cisplatin-induced neuropathy
Read More
Spectrum Pharmaceuticals reports second quarter 2007 results
Read More
FDA grants Tikvah Therapeutics' sodium phenylbutyrate orphan drug status
Read More
FDA issues approvable letter to Solvay for drug candidate Creon
Read More
Intercell reports interim data from phase II trial of HCV vaccine IC-41
Read More
Recent Merck patent claims compounds for the treatment of urinary incontinence
Read More
Design and pharmacological characterization of ILS-920 presented at ACS meeting
Read More
Macrogenics starts phase I trial of West Nile virus neutralizing antibody
Read More
Daiichi Sankyo selects DT-831j as clinical candidate for thrombosis
Read More
Thymoglobulin to be studied in new onset type 1 diabetes
Read More
Lexicon pursues compounds able to reduce peripheral 5-HT levels as an approach to IBS
Read More
Novel PPARalpha/gamma agonists improve blood glucose and lipid profiles in animals
Read More
Clinical candidate NYP Y5 antagonist discovered at Banyu
Read More
BMS designs dual PPARalpha/gamma activators for metabolic disorders
Read More